Direct-To-Consumer (DTC) Genetic Testing Market Projected at $3.9 Billion by 2029 | Strategic Insights and Forecast Data
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Direct-To-Consumer (DTC) Genetic Testing Market Size Changed, over the years?
The market size for direct-to-consumer (DTC) genetic testing has seen a fast-paced growth in recent times. The predictions point out an expansion from $1.84 billion in 2024 to $2.14 billion in 2025, reflecting a compound annual growth rate (CAGR) of 16.2%. Factors accountable for the growth during the previous period include interest in discovering lineage and heritage, trends in health and wellness, marketing and consumer education efforts, privacy concerns, and control over genetic data, along with affordability and easy access.
How Much Will the Direct-To-Consumer (DTC) Genetic Testing Market Be Worth in 2029?
Expectations predict a swift expansion in the direct-to-consumer (DTC) genetic testing market in the coming years, with a projected growth up to $3.9 billion in 2029, registering a compound annual growth rate (CAGR) of 16.2%. This projected development during the prediction period is largely credited to factors such as widened test offerings, merging with personalized medicine, associations with health and wellness sectors, advancements in the field of genetic study, along with government regulations and support. Major trends expected during this forecast period include enhanced test offerings and panels, consumer-driven educational pursuits, regulation adherence and supervision, genomic data research endeavors, and improving accessibility due to reduced pricing.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8957&type=smp
Which is the Largest Company in the Direct-To-Consumer (DTC) Genetic Testing Market?
Major companies operating in the direct-to-consumer (DTC) genetic testing market include 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA, Living DNA, Vitagene, Orig3n, DNAfit, Helix, Color Genomics, Circle DNA, CRI Genetics, MapMyGenome, Invitae Corporation, TellmeGen, Pathway Genomics, Genebase Systems, EasyDNA, Nebula Genomics, Dante Labs, Veritas Genetics, Xcode Life, Genomic Express, Genomelink, Genomind, WellnessFX, LetsGetChecked, iGene, Dnadoc, OneOme
What Are the Main Market Drivers in the Direct-To-Consumer (DTC) Genetic Testing Industry?
The escalating occurrence of illnesses and conditions capable of genetic transmission is anticipated to spark expansion in the direct-to-consumer (DTC) genetic testing market in the future. A genetic disorder is an ailment caused by alterations (mutation) in an individual’s DNA, encompassing single-gene, multifactorial, and chromosomal disorders. DTC genetic testing heightens cognizance about various genetic conditions, facilitating predictions regarding health while delivering customized health information about an individual’s health, disease risk, and other traits, thus aiding in making effective health and lifestyle choices to diminish the risk of disease. As an illustration, in April 2023, the US-based National Library of Medicine (NLM) reported an estimated 6.7 million Americans aged 65 and over will be diagnosed with Alzheimer’s dementia (AD) by 2023, a condition in which genetics play a critical role. This figure might escalate to 13.8 million by 2060 unless medical advancements manage to prevent, decelerate, or cure AD. Consequently, the escalating occurrence of illnesses and conditions capable of genetic transmission fuels the expansion of the direct-to-consumer (DTC) genetic testing market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=8957&type=smp
How Is the Direct-To-Consumer (DTC) Genetic Testing Market Segments Structured?
The direct-to-consumer (DTC) genetic testing market covered in this report is segmented –
1) By Type: Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types
2) By Sample: Saliva, Urine, Blood
3) By Technology: Single Nucleotide Polymorphism Chips, Whole Genome Sequencing, Targeted Analysis
4) By Business Model: Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Mode
5) By End User: Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centers, Home Care, Cosmetics, Other End-User
Subsegments:
1) By Carrier Testing: Autosomal Recessive Disorders, X-Linked Disorders
2) By Predictive Testing: Risk Assessment For Genetic Conditions, Adult-Onset Conditions
3) By Ancestry And Relationship Testing: Ancestry Composition Analysis, DNA Matching For Relationships
4) By Nutrigenomic Testing: Dietary Recommendations, Metabolism And Fitness Insights
5) By Other Types: Pharmacogenomic Testing, Health Trait Testing
What Strategic Trends Are Transforming the Direct-To-Consumer (DTC) Genetic Testing Market?
Leading corporations in the direct-to-consumer (DTC) genetic testing sector are prioritizing investment in genetic research to maintain market dominance. These investments offer the financial support needed for these companies to carry out research, improve technologies, extend their market footprint, ensure regulatory compliance, and fuel innovation. For example, Redcliffe Labs, a diagnostic and testing laboratory based in India, announced in November 2022 its strategy to invest an extra $10 million (approximately Rs 81 crore) in broadening its genetic and specialized testing offerings. This investment aims to enhance the company’s capabilities in genetic testing, covering areas like prenatal, oncology, neurology, nephrology, and pharmacogenomics. The company has already committed $6 million towards genetics and specialized testing coverage and is now aiming to invest in next-gen technologies in the diagnostic field.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Direct-To-Consumer (DTC) Genetic Testing Market?
North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2024. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8957
This Report Delivers Insight On:
1. How big is the direct-to-consumer (dtc) genetic testing market, and how is it changing globally?
2. Who are the major companies in the direct-to-consumer (dtc) genetic testing market, and how are they performing?
3. What are the key opportunities and risks in the direct-to-consumer (dtc) genetic testing market right now?
4. Which products or customer segments are growing the most in the direct-to-consumer (dtc) genetic testing market?
5. What factors are helping or slowing down the growth of the direct-to-consumer (dtc) genetic testing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
